202 related articles for article (PubMed ID: 38566223)
21. Updating targets for natural killer/T-cell lymphoma immunotherapy.
Xue W; Zhang M
Cancer Biol Med; 2021 Feb; 18(1):52-62. PubMed ID: 33628584
[TBL] [Abstract][Full Text] [Related]
22. HACE1, a potential tumor suppressor gene on 6q21, is not involved in extranodal natural killer/T-cell lymphoma pathophysiology.
Sako N; Dessirier V; Bagot M; Bensussan A; Schmitt C
Am J Pathol; 2014 Nov; 184(11):2899-907. PubMed ID: 25203537
[TBL] [Abstract][Full Text] [Related]
23. Extranodal NK/T-cell lymphoma: toward the identification of clinical molecular targets.
Schmitt C; Sako N; Bagot M; Huang Y; Gaulard P; Bensussan A
J Biomed Biotechnol; 2011; 2011():790871. PubMed ID: 21541194
[TBL] [Abstract][Full Text] [Related]
24. [Clinical differences between primary nasopharyngeal NK/T-cell lymphoma and primary nasal cavity NK/T-cell lymphoma with nasopharynx extension].
Liu WX; Liu YP; Jin J; Wang SL; Fang H; Ren H; Song YW; Chen B; Lu NN; Li N; Tang Y; Qi SN; Tang Y; Wang WH; Li YX
Zhonghua Zhong Liu Za Zhi; 2019 Jan; 41(1):56-62. PubMed ID: 30678418
[No Abstract] [Full Text] [Related]
25. T-cell dysfunction in natural killer/T-cell lymphoma.
Feng X; Meng M; Li H; Gao Y; Song W; Di R; Li Z; Zhang X; Zhang M
Oncoimmunology; 2023; 12(1):2212532. PubMed ID: 37250921
[TBL] [Abstract][Full Text] [Related]
26. Immunophenotypic and clinical differences between the nasal and extranasal subtypes of upper aerodigestive tract natural killer/T-cell lymphoma.
Liu QF; Wang WH; Wang SL; Liu YP; Huang WT; Lu N; Zhou LQ; Ouyang H; Jin J; Li YX
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):806-13. PubMed ID: 24495590
[TBL] [Abstract][Full Text] [Related]
27. PD-L1 is upregulated by EBV-driven LMP1 through NF-κB pathway and correlates with poor prognosis in natural killer/T-cell lymphoma.
Bi XW; Wang H; Zhang WW; Wang JH; Liu WJ; Xia ZJ; Huang HQ; Jiang WQ; Zhang YJ; Wang L
J Hematol Oncol; 2016 Oct; 9(1):109. PubMed ID: 27737703
[TBL] [Abstract][Full Text] [Related]
28. Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type.
Huang Y; de Reyniès A; de Leval L; Ghazi B; Martin-Garcia N; Travert M; Bosq J; Brière J; Petit B; Thomas E; Coppo P; Marafioti T; Emile JF; Delfau-Larue MH; Schmitt C; Gaulard P
Blood; 2010 Feb; 115(6):1226-37. PubMed ID: 19965620
[TBL] [Abstract][Full Text] [Related]
29. SLC1A1 mediated glutamine addiction and contributed to natural killer T-cell lymphoma progression with immunotherapeutic potential.
Xiong J; Wang N; Zhong HJ; Cui BW; Cheng S; Sun R; Chen JY; Xu PP; Cai G; Wang L; Sun XJ; Huang JY; Zhao WL
EBioMedicine; 2021 Oct; 72():103614. PubMed ID: 34628354
[TBL] [Abstract][Full Text] [Related]
30. Clinical disparity and favorable prognoses for patients with Waldeyer ring extranodal nasal-type NK/T-cell lymphoma and diffuse large B-cell lymphoma.
Wu RY; Li YX; Wang WH; Jin J; Wang SL; Liu YP; Song YW; Fang H; Ren H; Liu QF; Wang ZY; Qi SN; Lu NN; Chen B; Zhang XM; Zhou LQ; Liu XF; Yu ZH
Am J Clin Oncol; 2014 Feb; 37(1):41-6. PubMed ID: 22992625
[TBL] [Abstract][Full Text] [Related]
31. The aberrant activation of Wnt pathway caused by β-catenin mutation and its prognostic significance in NK/T-cell lymphoma.
Qin BB; Tang DF; Ni ML; Gao W; Zhang MZ
Neoplasma; 2019 Jan; 66(1):20-27. PubMed ID: 30509083
[TBL] [Abstract][Full Text] [Related]
32. Calreticulin increases growth and progression of natural killer/T-cell lymphoma.
Zheng Y; Li C; Xin P; Peng Q; Zhang W; Liu S; Zhu X
Aging (Albany NY); 2020 Nov; 12(23):23822-23835. PubMed ID: 33221760
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-155 is a potential molecular marker of natural killer/T-cell lymphoma.
Zhang X; Ji W; Huang R; Li L; Wang X; Li L; Fu X; Sun Z; Li Z; Chen Q; Zhang M
Oncotarget; 2016 Aug; 7(33):53808-53819. PubMed ID: 27462776
[TBL] [Abstract][Full Text] [Related]
34. Daratumumab monotherapy for patients with relapsed or refractory natural killer/T-cell lymphoma, nasal type: an open-label, single-arm, multicenter, phase 2 study.
Huang H; Zhu J; Yao M; Kim TM; Yoon DH; Cho SG; Eom HS; Lim ST; Yeh SP; Song Y; Kwong YL; Kim JS; Jin J; Shi Y; Kim H; Qing M; Zhou T; Gao G; Dong Z; Qi M; Kim WS
J Hematol Oncol; 2021 Feb; 14(1):25. PubMed ID: 33588922
[TBL] [Abstract][Full Text] [Related]
35. Novel target and treatment agents for natural killer/T-cell lymphoma.
Tian XP; Cao Y; Cai J; Zhang YC; Zou QH; Wang JN; Fang Y; Wang JH; Guo SB; Cai QQ
J Hematol Oncol; 2023 Jul; 16(1):78. PubMed ID: 37480137
[TBL] [Abstract][Full Text] [Related]
36. Successful treatment with anti-programmed-death-1 antibody in a relapsed natural killer/T-cell lymphoma patient with multi-line resistance: a case report.
Lai J; Xu P; Jiang X; Zhou S; Liu A
BMC Cancer; 2017 Jul; 17(1):507. PubMed ID: 28754096
[TBL] [Abstract][Full Text] [Related]
37. MTMR2 promotes the progression of NK/T cell lymphoma by targeting JAK1.
Wang J; He AL; Zhang WG; Cao XM; Chen YX; Liu J; Zhao WH; Yang Y; Wang JL; Liu HL; Ma XR
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8057-8066. PubMed ID: 32767332
[TBL] [Abstract][Full Text] [Related]
38. Platelet-derived growth factor receptor alpha (PDGFRα) is overexpressed in NK/T-cell lymphoma and mediates cell survival.
Lu L; Fu X; Li Z; Qiu Y; Li W; Zhou Z; Xue W; Wang Y; Jin M; Zhang M
Biochem Biophys Res Commun; 2018 Oct; 504(2):525-531. PubMed ID: 30201265
[TBL] [Abstract][Full Text] [Related]
39. Association between higher expression of YB-1 and poor prognosis in early-stage extranodal nasal-type natural killer/T-cell lymphoma.
Zhao Z; Liao Y; Li J; Wu J; Zhang Y; Feng G; Tan B; Reng S; Zhang Z; Feng X; Wang J; Du X
Biomark Med; 2014; 8(4):581-8. PubMed ID: 24796623
[TBL] [Abstract][Full Text] [Related]
40. Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma.
Xiong J; Cui BW; Wang N; Dai YT; Zhang H; Wang CF; Zhong HJ; Cheng S; Ou-Yang BS; Hu Y; Zhang X; Xu B; Qian WB; Tao R; Yan F; Hu JD; Hou M; Ma XJ; Wang X; Liu YH; Zhu ZM; Huang XB; Liu L; Wu CY; Huang L; Shen YF; Huang RB; Xu JY; Wang C; Wu DP; Yu L; Li JF; Xu PP; Wang L; Huang JY; Chen SJ; Zhao WL
Cancer Cell; 2020 Mar; 37(3):403-419.e6. PubMed ID: 32183952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]